These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11998214)

  • 21. Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization.
    Li M; Song JL; Zhao Y; Wu SL; Liu HB; Tang R; Yan L
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):1022-1025. PubMed ID: 29119739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of endometrial hyperplasia: an evaluation of current practice.
    Clark TJ; Neelakantan D; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):259-64. PubMed ID: 16246481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
    Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
    Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endometrial hyperplasias revisited.
    Sivridis E; Giatromanolaki A
    Virchows Arch; 2008 Sep; 453(3):223-31. PubMed ID: 18726114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnosis of endometrial hyperplasia on curettage: how reliable is it?
    Obeidat B; Mohtaseb A; Matalka I
    Arch Gynecol Obstet; 2009 Apr; 279(4):489-92. PubMed ID: 18679697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resectoscopic treatment of atypical endometrial polyps in fertile women.
    Scrimin F; Wiesenfeld U; Candiotto A; Inglese S; Ronfani L; Guaschino S
    Am J Obstet Gynecol; 2008 Oct; 199(4):365.e1-3. PubMed ID: 18928975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress on surgical treatment and prevention of recurrence in endometrial polyps].
    Wang X; Huang XH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):307-10. PubMed ID: 21609583
    [No Abstract]   [Full Text] [Related]  

  • 30. [Endometrial hyperplasia, diagnosis. Clinical, paraclinical exam and management].
    Pangal A; Costăchescu G; Aldea MJ
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):445-9. PubMed ID: 20700983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia.
    Ismail MT; Fahmy DM; Elshmaa NS
    Reprod Sci; 2013 Jan; 20(1):45-50. PubMed ID: 23203322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens.
    Garuti G; Mirra M; Luerti M
    J Minim Invasive Gynecol; 2006; 13(4):325-30. PubMed ID: 16825075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perimenopausal bleeding: Patterns, pathology, response to progestins and clinical outcome.
    Rezk M; Masood A; Dawood R
    J Obstet Gynaecol; 2015; 35(5):517-21. PubMed ID: 25383726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Conservative treatment of endometrial cancer and atypical hyperplasia].
    Yazbeck C; Dhainaut C; Thoury A; Driguez P; Madelenat P
    Gynecol Obstet Fertil; 2004 May; 32(5):433-41. PubMed ID: 15177216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and management of endometrial hyperplasia.
    Armstrong AJ; Hurd WW; Elguero S; Barker NM; Zanotti KM
    J Minim Invasive Gynecol; 2012; 19(5):562-71. PubMed ID: 22863972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer.
    Lai CH; Huang HJ
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):29-34. PubMed ID: 16493257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Balloon thermoablation in a woman with complex endometrial hyperplasia with atypia. A case report.
    Minassian VA; Mira JL
    J Reprod Med; 2001 Oct; 46(10):933-6. PubMed ID: 11725742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.
    Gunderson CC; Fader AN; Carson KA; Bristow RE
    Gynecol Oncol; 2012 May; 125(2):477-82. PubMed ID: 22245711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.